{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:25:49Z","timestamp":1790141149715,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.sleep.2025.106706","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:03Z","timestamp":1753891023000},"page":"106706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial"],"prefix":"10.1016","volume":"134","author":[{"given":"Jiucheng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaida","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4848-5903","authenticated-orcid":false,"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.sleep.2025.106706_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.sleep.2025.106706_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13690","article-title":"Correlates of excessive daytime sleepiness in obstructive sleep apnea: results from the nationwide SESAR cohort including 34,684 patients","volume":"31","author":"Ulander","year":"2022","journal-title":"J Sleep Res"},{"issue":"3","key":"10.1016\/j.sleep.2025.106706_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.21037\/jtd.2018.03.135","article-title":"Treatment choice by patients with obstructive sleep apnea: data from two centers in China","volume":"10","author":"Liao","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.sleep.2025.106706_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101275","article-title":"The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea","volume":"51","author":"Leger","year":"2020","journal-title":"Sleep Med Rev"},{"issue":"7","key":"10.1016\/j.sleep.2025.106706_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1513\/AnnalsATS.202208-676OC","article-title":"Cardiovascular outcomes in adults with coronary artery disease and obstructive sleep apnea with versus without excessive daytime sleepiness in the RICCADSA cinical trial","volume":"20","author":"Eulenburg","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.sleep.2025.106706_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-159-7-201310010-00704","article-title":"Management of obstructive sleep apnea in adults: a clinical practice guideline from the American college of physicians","volume":"159","author":"Qaseem","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.106706_bib8","article-title":"Predictors of the efficacy for daytime sleepiness in patients with obstructive sleep apnea with continual positive airway pressure therapy: a meta-analysis of randomized controlled trials","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.sleep.2025.106706_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.5664\/jcsm.8476","article-title":"Racial disparities in positive airway pressure therapy adherence among veterans with obstructive sleep apnea","volume":"16","author":"Hsu","year":"2020","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2025.106706_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5664\/jcsm.9544","article-title":"The association of age with continuous positive airway pressure ventilation acceptance in an outpatient cohort of patients with obstructive sleep apnea","volume":"18","author":"Han","year":"2022","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2025.106706_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/crj.13269","article-title":"Acceptance of and six-month adherence to continuous positive airway pressure in patients with moderate to severe obstructive sleep apnea","volume":"15","author":"Luo","year":"2021","journal-title":"Clin Res J"},{"issue":"20","key":"10.1016\/j.sleep.2025.106706_bib12","first-page":"1578","article-title":"[A cross-sectional survey of treatment acceptance and influence factors in patients with obstructive sleep apnea","volume":"98","author":"Chen","year":"2018","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"1","key":"10.1016\/j.sleep.2025.106706_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s41105-017-0132-8","article-title":"Age- and gender-related differences of CPAP acceptance for obstructive sleep apnea syndrome in Taiwan","volume":"16","author":"Huang","year":"2018","journal-title":"Sleep Biol Rhythm"},{"issue":"1","key":"10.1016\/j.sleep.2025.106706_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","article-title":"Trends in CPAP adherence over twenty years of data collection: a flattened curve","volume":"45","author":"Rotenberg","year":"2016","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00348-2017","article-title":"Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy","volume":"50","author":"Budhiraja","year":"2017","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chest.2020.02.036","article-title":"Update on persistent excessive daytime sleepiness in OSA","volume":"158","author":"Javaheri","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2025.106706_bib17","series-title":"Sunosi\u2122 (solriamfetol) tablets prescribing information","year":"2023"},{"key":"10.1016\/j.sleep.2025.106706_bib18","series-title":"Sunosi\u2122 (solriamfetol) tablets summary of product characteristics","year":"2025"},{"issue":"11","key":"10.1016\/j.sleep.2025.106706_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3). A randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","article-title":"Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study","volume":"155","author":"Strollo","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz220","article-title":"Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea","volume":"43","author":"Malhotra","year":"2020","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2025.106706_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2021.02.033","article-title":"Randomized controlled trial of solriamfetol for excessive daytime sleepiness in OSA: an analysis of subgroups adherent or nonadherent to OSA treatment","volume":"160","author":"Schweitzer","year":"2021","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.sleep.2025.106706_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5664\/jcsm.8992","article-title":"Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy","volume":"17","author":"Schweitzer","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.106706_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101997","article-title":"Excessive daytime sleepiness in obstructive sleep apnea: indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy","volume":"78","author":"Wang","year":"2024","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4187\/respcare.01136","article-title":"Adherence to CPAP in patients with obstructive sleep apnea in a Chinese population","volume":"57","author":"Wang","year":"2012","journal-title":"Respir Care"},{"key":"10.1016\/j.sleep.2025.106706_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sleep.2019.01.004","article-title":"Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data","volume":"59","author":"Cistulli","year":"2019","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz273","article-title":"Differences in three-dimensional upper airway anatomy between Asian and European patients with obstructive sleep apnea","volume":"43","author":"Xu","year":"2020","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0013-4694(97)00010-2","article-title":"A normative study of the maintenance of wakefulness test (MWT)","volume":"103","author":"Doghramji","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.mayocp.2020.08.033","article-title":"Excessive daytime sleepiness: a clinical review","volume":"96","author":"Gandhi","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2025.106706_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2019.11.587","article-title":"Thresholds for clinically meaningful changes on the epworth sleepiness scale and maintenance of wakefulness test sleep latency","volume":"64","author":"Lammers","year":"2019","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5664\/jcsm.3444","article-title":"Depression may reduce adherence during CPAP titration trial","volume":"10","author":"Law","year":"2014","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2025.106706_bib33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.sleep.2025.106706_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/thoraxjnl-2013-203796","article-title":"Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial","volume":"69","author":"Chapman","year":"2014","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of Solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"2","key":"10.1016\/j.sleep.2025.106706_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pnpbp.2007.10.016","article-title":"Placebo and modafinil effect on sleepiness in obstructive sleep apnea","volume":"32","author":"Bittencourt","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.sleep.2025.106706_bib37","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.sleep.2025.106706_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","article-title":"Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2025.106706_bib39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.sleep.2025.106706_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.sleep.2025.106706_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2845","article-title":"Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea","volume":"37","author":"Vinckenbosch","year":"2022","journal-title":"Hum Psychopharmacol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:15:56Z","timestamp":1772781356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S1389945725003818"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106706","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106706"}}